Q-omics provides the consensus-scored RPL31P60 profile across patient tissues and cancer cell-line models. RPL31P60 expression is associated with patient survival in 16 of 34 cancer types, with the highest sampling consensus in HNSC. Additionally, RPL31P60 RNA expression shows 6,423 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight HNSC, and STAD as cancer lineages where RPL31P60 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.